News

 

At AseBio, we follow the latest news in the biotechnology sector and pass the highlights on to you. You can use the search engine to find news articles we’ve written, contributed by our members or from other stakeholders in the sector. And they are also organised into categories to help you find the topics you’re interested in easily.

Search engine
judit
Nuage Therapeutics appoints biotech entrepreneur and executive Judit Anido as CEO
Healthcare · Access to innovation · Corporate
Judit Anido joins Nuage Therapeutics as co-founder and CEO and becomes member of the Board of…
biospain
Barcelona to host BIOSPAIN 2023 international conference on biotechnology
International
AseBio, in collaboration with Biocat, the Government of Catalonia and the Barcelona City Council,…
ory
ORYZON reports results and corporate update for quarter ended March 31, 2022
Healthcare
Oryzon Genomics, S.A., today reported financial results for the first quarter of 2022 and provided…
bcn
Conference “Jornada de Acceso al Mercado de Medicamentos, Tratamientos de Coste Elevado y Medición de Resultados en Salud”
Healthcare
BCN HEALTH is organising the conference “Jornada de Acceso al Mercado de Medicamentos, Tratamientos…
jj
Digital Therapeutics Leader Sidekick Raises $55M Series B To Drive Further Growth
Financing
The closing of the company’s B Series follows an oversubscribed $20m A round in 2020
Rosa Planelles
“AseBio Investor Day 2022 showcased a bubbling biotech sector”
International · Financing · Digitalization
It’s been a week since AseBio’s event of the year, which brought together some 145 organisations…
jjj
El 52% de los hombres españoles considera que los problemas de salud masculinos son un tema tabú
Healthcare
De entre las distintas patologías, confiesan que se sienten menos cómodos al hablar de salud sexual…
Celtarys
#NewMember | "AseBio is a reference in the promotion and visibility of the biotech sector in Spain"
Healthcare · Drug discovery
Meet Celtarys Research, our new member. We talk with Sonia…
ww
ORYZON starts preclinical collaboration on Kabuki syndrome with Kennedy Krieger Institute and Johns Hopkins University
Healthcare
Oryzon Genomics, S.A, announced today the start of a preclinical collaboration on Kabuki…